Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Eurofins Scientific announced it has signed an agreement to acquire GATC Biotech AG, one of Europe’s specialists in DNA sequencing.
read more
Chesapeake IRB announced it has acquired MaGil IRB, a central IRB located in Rockville, Md.
read more
Evoke Pharma announced that it has entered into an agreement with Rho, Inc., a regulatory consulting and contract research organization.
read more
Novatek International has been selected by Boehringer Ingelheim as their approved Vendor and Partner for a worldwide solution for Environmental Monitoring Software.
read more
In the pharmaceutical industry, the traceability of prescription drugs is increasingly vital to the integrity of these products.
read more
The global pharmaceutical contract manufacturing/contract research market is anticipated to reach USD 238.3 billion by 2025, according to a new report by Grand View Research.
read more
Marken announced the launch of their Direct to Patient (DTP) White Book Industry Guide.
read more
Bristol-Myers Squibb and QIAGEN signed an agreement to explore the use of NGS technology to develop GEPs as predictive or prognostic tools for use with Bristol-Myers Squibb novel I-O therapies in cancer treatment.
read more
Helsinn and MEI Pharma announced findings from a genetic mutation analysis of patients in a Phase II clinical study of the investigational drug pracinostat and azacitidine in AML.
read more
Cambrex announced that it has expanded large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden.
read more
Sanofi and Regeneron announced positive preliminary results with investigational REGN2810, a checkpoint inhibitor targeting PD-1, in patients with advanced CSCC.
read more
Immunoprecise Antibodies announced the opening of its 3,200 square foot antibody production laboratory at Vancouver Island Technology Park.
read more
F-star announced a new partnership with Merck for the development and commercialization of five bispecific immuno-oncology antibodies (mAb2).
read more
Accenture will acquire LabAnswer, a U.S.-based research and laboratory informatics technology consulting firm. Terms of the acquisition were not disclosed.
read more
Ligand Pharmaceuticals has entered into a worldwide license agreement with Cambridge, Massachusetts-based Surface Oncology.
read more